Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Orphanet Journal of Rare Diseases

eISSN: 1750-1172pISSN: 1750-1172
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Aims and Scope

The Orphanet Journal of Rare Diseases is a peer-reviewed open access medical journal covering research on rare diseases. It was established in 2006 and the editor-in-chief is Francesc Palau (Hospital Sant Joan de Déu Barcelona and CIBERER, Spain). It is an official journal of Orphanet and is published by BioMed Central, which is part of Springer Nature. Less

Key Metrics

CiteScore
5.2
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Genetics (clinical)
SNIP
1.78
Time to Publish
time-to-publish View Chart
5  Mo

Journal Specifications

Overview
  • Publisher
    BMC
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    EUR 2290 | USD 2790 | GBP 1990
  • Publication Time
    16
  • Editorial Review Process
    Anonymous peer review
General Details
  • Language
    English
  • Society/Institute/Sponsor
    Orphanet
  • Frequency
    Continuous publication
  • Publication Start Year
    2006
  • Publisher URL
  • Website URL
Publication Details
Editorial Review Detail
Information for authors
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 6%
4-6 59%
7-9 26%
>9 9%

Topics Covered

Quality of life
Newborn screening
Tuberous sclerosis
Oxidative stress
Adult patients
Rare disease
Spinal muscular atrophy
Confidence interval
Angioedema
Hypertrophic cardiomyopathy
Enzyme defect
Central nervous system
Lung
Mucopolysaccharidosis
Neurofibromatosis
Methylmalonic acidemia
Achondroplasia
Genotype
Mental health
Median

Recently Published Papers

Year-wise Publication

FAQs

Since when has Orphanet Journal of Rare Diseases been publishing? Faqs

The Orphanet Journal of Rare Diseases has been publishing since 2006 till date.

How frequently is the Orphanet Journal of Rare Diseases published? Faqs

Orphanet Journal of Rare Diseases is published Continuous publication.

Who is the publisher of Orphanet Journal of Rare Diseases? Faqs

The publisher of Orphanet Journal of Rare Diseases is BMC.

Where can I find a journal's aims and scope of Orphanet Journal of Rare Diseases? Faqs

For the Orphanet Journal of Rare Diseases's Aims and Scope, please refer to the section above on the page.

How can I view the journal metrics of Orphanet Journal of Rare Diseases on editage? Faqs

For the Orphanet Journal of Rare Diseases metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Orphanet Journal of Rare Diseases? Faqs

The eISSN number is 1750-1172 and pISSN number is 1750-1172 for Orphanet Journal of Rare Diseases.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Quality of life, Newborn screening, Tuberous sclerosis, Oxidative stress, Adult patients, Rare disease, Spinal muscular atrophy, Confidence interval, Angioedema, Hypertrophic cardiomyopathy, Enzyme defect, Central nervous system, Lung, Mucopolysaccharidosis, Neurofibromatosis, Methylmalonic acidemia, Achondroplasia, Genotype, Mental health, Median.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.